Company intelligence / Profile preview

NeuroInvestment

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

NeuroInvestment is a specialized research and consulting firm focused exclusively on the Central Nervous System (CNS) drug development sector. The company provides in-depth analysis, market intelligence, and strategic consulting for investors, pharmaceutical companies, and biotechnology firms interested in neurology and psychiatry. Known for its monthly publication, also titled NeuroInvestment, the firm evaluates clinical trial data, regulatory pathways, and commercial prospects for therapies targeting disorders such as Alzheimer's disease and Parkinson's disease. It serves as a niche advisory for stakeholders navigating the high-risk, high-reward landscape of CNS therapeutics.

Therapeutic areas: PsychiatryNeurology
Industry: Consulting

Beyond the preview

Go deeper on NeuroInvestment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroInvestment.

Explore the full profile